Tue, 21 Aug 2018 05:15:02 GMT
Gao-led consortium makes takeover bid for China Biologic
On Monday, China Biologic Products received a $3.9B worth all-cash proposal from a consortium, which includes Bank of China Group, CDH Investments and GL Capital Group, led by the firm's former CEO Davd Gao.